Triple-negative breast cancer cell lines treated with mebedazole (an FDA-approved anti-parasitic).
Ontology highlight
ABSTRACT: Triple-negative breast cancer cell lines treated with mebedazole (an FDA-approved anti-parasitic).
PROVIDER: PRJNA788559 | ENA |
REPOSITORIES: ENA
ACCESS DATA